Characterization of the physicochemical interactions between exenatide and two intestinal permeation enhancers: Sodium caprate (C10) and salcaprozate sodium (SNAC).

Twarog, Caroline et al.·International journal of pharmaceutics·2022·
RPEP-065522022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Exenatide showed weak interactions with sodium caprate and SNAC, with dissociation constants of approximately 10 µM and 30 µM, respectively.

Key Numbers

How They Did This

The study employed dynamic light scattering, surface plasmon resonance, isothermal titration calorimetry, and affinity capillary electrophoresis to analyze the interactions.

Why This Research Matters

Understanding these interactions is crucial for improving the oral bioavailability of peptide drugs like exenatide. This knowledge could lead to better formulations for effective oral delivery.

What This Study Doesn't Tell Us

The study primarily focuses on in vitro interactions, which may not fully represent in vivo conditions in the human gastrointestinal tract.

Trust & Context

Original Title:
Characterization of the physicochemical interactions between exenatide and two intestinal permeation enhancers: Sodium caprate (C10) and salcaprozate sodium (SNAC).
Published In:
International journal of pharmaceutics, 626, 122131 (2022)
Database ID:
RPEP-06552

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06552·https://rethinkpeptides.com/research/RPEP-06552

APA

Twarog, Caroline; Fattal, Elias; Noiray, Magali; Illel, Brigitte; Brayden, David J; Taverna, Myriam; Hillaireau, Hervé. (2022). Characterization of the physicochemical interactions between exenatide and two intestinal permeation enhancers: Sodium caprate (C10) and salcaprozate sodium (SNAC).. International journal of pharmaceutics, 626, 122131. https://doi.org/10.1016/j.ijpharm.2022.122131

MLA

Twarog, Caroline, et al. "Characterization of the physicochemical interactions between exenatide and two intestinal permeation enhancers: Sodium caprate (C10) and salcaprozate sodium (SNAC).." International journal of pharmaceutics, 2022. https://doi.org/10.1016/j.ijpharm.2022.122131

RethinkPeptides

RethinkPeptides Research Database. "Characterization of the physicochemical interactions between..." RPEP-06552. Retrieved from https://rethinkpeptides.com/research/twarog-2022-characterization-of-the-physicochemical

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.